{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:16:05Z","timestamp":1778620565529,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020KH006"],"award-info":[{"award-number":["ZR2020KH006"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170609"],"award-info":[{"award-number":["82170609"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970545"],"award-info":[{"award-number":["81970545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.cgh.2022.02.008","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T17:23:20Z","timestamp":1644341000000},"page":"2210-2215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Nonalcoholic Fatty Liver Disease in Children: Where Are We?"],"prefix":"10.1016","volume":"20","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramsey","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.02.008_bib1","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","author":"Le","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.02.008_bib2","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.14309\/ajg.0000000000001386","article-title":"The changing epidemiology of liver disease among US children and adolescents from 1999 to 2016","volume":"116","author":"Li","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.02.008_bib3","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/j.gastro.2020.01.048","article-title":"nonalcoholic fatty liver disease in children: unique considerations and challenges","volume":"158","author":"Goldner","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.02.008_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/archdischild-2019-318063","article-title":"Non-alcoholic fatty liver disease and childhood obesity","volume":"106","author":"Shaunak","year":"2021","journal-title":"Arch Dis Childhood"},{"key":"10.1016\/j.cgh.2022.02.008_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.02.008_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","article-title":"Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children","volume":"20","author":"Kleiner","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2022.02.008_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/liv.14748","article-title":"Non-invasive diagnosis methods are needed in paediatric non-alcoholic fatty liver disease","volume":"41","author":"Li","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2022.02.008_bib8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.31317","article-title":"Alanine aminotransferase and gamma-glutamyl transpeptidase predict histologic improvement in pediatric nonalcoholic steatohepatitis","volume":"73","author":"Newton","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.02.008_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.02.008_bib10","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clinthera.2021.01.006","article-title":"Advances in the epidemiology, diagnosis, and management of pediatric fatty liver disease","volume":"43","author":"Suri","year":"2021","journal-title":"Clin Ther"},{"key":"10.1016\/j.cgh.2022.02.008_bib11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.29596","article-title":"Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease","volume":"67","author":"Middleton","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2022.02.008_bib12","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality","volume":"75","author":"Simon","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2022.02.008_bib13","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2022.02.008_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168216","article-title":"Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single centre trial","volume":"11","author":"Della Corte","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2022.02.008_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1053\/j.gastro.2016.08.027","article-title":"In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores","volume":"151","author":"Schwimmer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.02.008_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40814-018-0306-4","article-title":"A\u00a0randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease","volume":"4","author":"Vos","year":"2018","journal-title":"Pilot Feasibility Stud"},{"key":"10.1016\/j.cgh.2022.02.008_bib17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1365-2036.2011.04626.x","article-title":"Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease","volume":"33","author":"Dohil","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2022.02.008_bib18","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpeds.2015.01.056","article-title":"Omega-3 fatty acids therapy in children with nonalcoholic fatty liver disease: a randomized controlled trial","volume":"166","author":"Janczyk","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.cgh.2022.02.008_bib19","article-title":"The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: a randomized controlled trial","author":"Yurtda\u015f","year":"2021","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.cgh.2022.02.008_bib20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jama.2018.20579","article-title":"Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: a randomized clinical trial","volume":"321","author":"Schwimmer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2022.02.008_bib21","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.cgh.2021.11.039","article-title":"Intensive lifestyle management improves steatosis and fibrosis in pediatric nonalcoholic fatty liver disease","volume":"20","author":"Lefere","year":"2022","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652200132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235652200132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:29:21Z","timestamp":1778617761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235652200132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S154235652200132X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.02.008","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic Fatty Liver Disease in Children: Where Are We?","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.11.039","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the AGA Institute","name":"copyright","label":"Copyright"}]}}